Diabetes and metabolism Archives - Page 5 of 8

Diabetes and metabolism, Diet and nutrition

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Expert/s: Manuela Callari

Diabetes and metabolism

Clinical Articles

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Expert/s: Healthed

Diabetes and metabolism

Clinical Articles

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Expert/s: Healthed

Diabetes and metabolism

Clinical Articles

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Expert/s: Lindsey Schier, Dr Scott Kanoski

Diabetes and metabolism

Podcasts

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Expert/s: Dr Michael Hii

Diabetes and metabolism

Clinical Articles

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Expert/s: Dr Sarah Wood

Diabetes and metabolism

Clinical Articles

Obesity & metabolic syndrome in kids is a growing problem

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

Expert/s: Lynnette Hoffman

Diabetes and metabolism, Endocrinology, Ophthalmology

Videos

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Expert/s: Prof Richard O'Brien

Diabetes and metabolism

Clinical Articles

Routine screenings could prevent vision loss for diabetes patients

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Expert/s: Ben Falkenmire

Diabetes and metabolism

Clinical Articles

Low carb diets for T2D remission?

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Expert/s: Healthed

Diabetes and metabolism

Podcasts

Low carbohydrate diets to manage T2D

How Type 2 Diabetes (T2D) remission sounds impossible, but is achievable and endorsed by Diabetes Australia in their "Type 2 Diabetes Position Statement" October 2021, and The compelling and beneficial impact of introducing a low carb dietary intervention to patients with T2D, rather than surgery or prescribing more drugs.

Expert/s: Dr Peter Brukner OAM

Diabetes and metabolism, Surgery

Podcasts

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Expert/s: Prof John Dixon

Diabetes and metabolism

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Obesity & metabolic syndrome in kids is a growing problem

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Routine screenings could prevent vision loss for diabetes patients

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Low carb diets for T2D remission?

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Low carbohydrate diets to manage T2D

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Diabetes and metabolism

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Worldwide shortages cause to TGA put the brakes on prescribing

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.